Global Biosimilar Contract Manufacturing Market Growth (Status and Outlook) 2024-2030

Publication ID:

LPI10245897

Publication Date:

October 8, 2024

Pages:

124

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

IT Services [2]

Software [3]

Computing & Electronics [4]

Description:

The global Biosimilar Contract Manufacturing market size was valued at US$ million in 2023. With growing demand in downstream market, the Biosimilar Contract Manufacturing is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Biosimilar Contract Manufacturing market. Biosimilar Contract Manufacturing are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Biosimilar Contract Manufacturing. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Biosimilar Contract Manufacturing market.
The increasing popularity of听biosimilars听in treating diseases, such as cancer, autoimmune diseases, blood disorders, and others, and the low cost of biosimilars as compared to听biologics听are some of the major factors driving the market.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Biosimilar Contract Manufacturing market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Biosimilar Contract Manufacturing market. It may include historical data, market segmentation by Type (e.g., Recombinant Non-glycosylated Proteins, Recombinant Glycosylated Proteins), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Biosimilar Contract Manufacturing market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Biosimilar Contract Manufacturing market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Biosimilar Contract Manufacturing industry. This include advancements in Biosimilar Contract Manufacturing technology, Biosimilar Contract Manufacturing new entrants, Biosimilar Contract Manufacturing new investment, and other innovations that are shaping the future of Biosimilar Contract Manufacturing.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Biosimilar Contract Manufacturing market. It includes factors influencing customer ' purchasing decisions, preferences for Biosimilar Contract Manufacturing product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Biosimilar Contract Manufacturing market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Biosimilar Contract Manufacturing market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Biosimilar Contract Manufacturing market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Biosimilar Contract Manufacturing industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Biosimilar Contract Manufacturing market.
Market Segmentation:
Biosimilar Contract Manufacturing market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
Recombinant Non-glycosylated Proteins
Recombinant Glycosylated Proteins
Segmentation by application
Oncology
Blood Disorders
Growth Hormonal Deficiency
Chronic & Autoimmune Disorders
Rheumatoid Arthritis
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Boehringer Ingelheim Biopharmaceuticals GmbH
Lonza
Catalent, Inc.
Biocon
IQVIA Inc.
AGC Biologics
Samsung Biologics
WuXi Biologics
Element Materials Technology
Rentschler Biopharma SE
Avid Bioservices, Inc.
Alcami Corporation, Inc.
Fujifilm Kyowa Kirin Biologics Co., Ltd.
Thermo Fisher Scientific Inc.
Almac Group

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Biosimilar Contract Manufacturing Market Size 2019-2030
2.1.2 Biosimilar Contract Manufacturing Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Biosimilar Contract Manufacturing Segment by Type
2.2.1 Recombinant Non-glycosylated Proteins
2.2.2 Recombinant Glycosylated Proteins
2.3 Biosimilar Contract Manufacturing Market Size by Type
2.3.1 Biosimilar Contract Manufacturing Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Biosimilar Contract Manufacturing Market Size Market Share by Type (2019-2024)
2.4 Biosimilar Contract Manufacturing Segment by Application
2.4.1 Oncology
2.4.2 Blood Disorders
2.4.3 Growth Hormonal Deficiency
2.4.4 Chronic & Autoimmune Disorders
2.4.5 Rheumatoid Arthritis
2.4.6 Others
2.5 Biosimilar Contract Manufacturing Market Size by Application
2.5.1 Biosimilar Contract Manufacturing Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Biosimilar Contract Manufacturing Market Size Market Share by Application (2019-2024)
3 Biosimilar Contract Manufacturing Market Size by Player
3.1 Biosimilar Contract Manufacturing Market Size Market Share by Players
3.1.1 Global Biosimilar Contract Manufacturing Revenue by Players (2019-2024)
3.1.2 Global Biosimilar Contract Manufacturing Revenue Market Share by Players (2019-2024)
3.2 Global Biosimilar Contract Manufacturing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Biosimilar Contract Manufacturing by Regions
4.1 Biosimilar Contract Manufacturing Market Size by Regions (2019-2024)
4.2 Americas Biosimilar Contract Manufacturing Market Size Growth (2019-2024)
4.3 APAC Biosimilar Contract Manufacturing Market Size Growth (2019-2024)
4.4 Europe Biosimilar Contract Manufacturing Market Size Growth (2019-2024)
4.5 Middle East & Africa Biosimilar Contract Manufacturing Market Size Growth (2019-2024)
5 Americas
5.1 Americas Biosimilar Contract Manufacturing Market Size by Country (2019-2024)
5.2 Americas Biosimilar Contract Manufacturing Market Size by Type (2019-2024)
5.3 Americas Biosimilar Contract Manufacturing Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Biosimilar Contract Manufacturing Market Size by Region (2019-2024)
6.2 APAC Biosimilar Contract Manufacturing Market Size by Type (2019-2024)
6.3 APAC Biosimilar Contract Manufacturing Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Biosimilar Contract Manufacturing by Country (2019-2024)
7.2 Europe Biosimilar Contract Manufacturing Market Size by Type (2019-2024)
7.3 Europe Biosimilar Contract Manufacturing Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Biosimilar Contract Manufacturing by Region (2019-2024)
8.2 Middle East & Africa Biosimilar Contract Manufacturing Market Size by Type (2019-2024)
8.3 Middle East & Africa Biosimilar Contract Manufacturing Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Biosimilar Contract Manufacturing Market Forecast
10.1 Global Biosimilar Contract Manufacturing Forecast by Regions (2025-2030)
10.1.1 Global Biosimilar Contract Manufacturing Forecast by Regions (2025-2030)
10.1.2 Americas Biosimilar Contract Manufacturing Forecast
10.1.3 APAC Biosimilar Contract Manufacturing Forecast
10.1.4 Europe Biosimilar Contract Manufacturing Forecast
10.1.5 Middle East & Africa Biosimilar Contract Manufacturing Forecast
10.2 Americas Biosimilar Contract Manufacturing Forecast by Country (2025-2030)
10.2.1 United States Biosimilar Contract Manufacturing Market Forecast
10.2.2 Canada Biosimilar Contract Manufacturing Market Forecast
10.2.3 Mexico Biosimilar Contract Manufacturing Market Forecast
10.2.4 Brazil Biosimilar Contract Manufacturing Market Forecast
10.3 APAC Biosimilar Contract Manufacturing Forecast by Region (2025-2030)
10.3.1 China Biosimilar Contract Manufacturing Market Forecast
10.3.2 Japan Biosimilar Contract Manufacturing Market Forecast
10.3.3 Korea Biosimilar Contract Manufacturing Market Forecast
10.3.4 Southeast Asia Biosimilar Contract Manufacturing Market Forecast
10.3.5 India Biosimilar Contract Manufacturing Market Forecast
10.3.6 Australia Biosimilar Contract Manufacturing Market Forecast
10.4 Europe Biosimilar Contract Manufacturing Forecast by Country (2025-2030)
10.4.1 Germany Biosimilar Contract Manufacturing Market Forecast
10.4.2 France Biosimilar Contract Manufacturing Market Forecast
10.4.3 UK Biosimilar Contract Manufacturing Market Forecast
10.4.4 Italy Biosimilar Contract Manufacturing Market Forecast
10.4.5 Russia Biosimilar Contract Manufacturing Market Forecast
10.5 Middle East & Africa Biosimilar Contract Manufacturing Forecast by Region (2025-2030)
10.5.1 Egypt Biosimilar Contract Manufacturing Market Forecast
10.5.2 South Africa Biosimilar Contract Manufacturing Market Forecast
10.5.3 Israel Biosimilar Contract Manufacturing Market Forecast
10.5.4 Turkey Biosimilar Contract Manufacturing Market Forecast
10.5.5 GCC Countries Biosimilar Contract Manufacturing Market Forecast
10.6 Global Biosimilar Contract Manufacturing Forecast by Type (2025-2030)
10.7 Global Biosimilar Contract Manufacturing Forecast by Application (2025-2030)

11 Key Players Analysis
11.1 Boehringer Ingelheim Biopharmaceuticals GmbH
11.1.1 Boehringer Ingelheim Biopharmaceuticals GmbH Company Information
11.1.2 Boehringer Ingelheim Biopharmaceuticals GmbH Biosimilar Contract Manufacturing Product Offered
11.1.3 Boehringer Ingelheim Biopharmaceuticals GmbH Biosimilar Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Boehringer Ingelheim Biopharmaceuticals GmbH Main Business Overview
11.1.5 Boehringer Ingelheim Biopharmaceuticals GmbH Latest Developments
11.2 Lonza
11.2.1 Lonza Company Information
11.2.2 Lonza Biosimilar Contract Manufacturing Product Offered
11.2.3 Lonza Biosimilar Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Lonza Main Business Overview
11.2.5 Lonza Latest Developments
11.3 Catalent, Inc.
11.3.1 Catalent, Inc. Company Information
11.3.2 Catalent, Inc. Biosimilar Contract Manufacturing Product Offered
11.3.3 Catalent, Inc. Biosimilar Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Catalent, Inc. Main Business Overview
11.3.5 Catalent, Inc. Latest Developments
11.4 Biocon
11.4.1 Biocon Company Information
11.4.2 Biocon Biosimilar Contract Manufacturing Product Offered
11.4.3 Biocon Biosimilar Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Biocon Main Business Overview
11.4.5 Biocon Latest Developments
11.5 IQVIA Inc.
11.5.1 IQVIA Inc. Company Information
11.5.2 IQVIA Inc. Biosimilar Contract Manufacturing Product Offered
11.5.3 IQVIA Inc. Biosimilar Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 IQVIA Inc. Main Business Overview
11.5.5 IQVIA Inc. Latest Developments
11.6 AGC Biologics
11.6.1 AGC Biologics Company Information
11.6.2 AGC Biologics Biosimilar Contract Manufacturing Product Offered
11.6.3 AGC Biologics Biosimilar Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 AGC Biologics Main Business Overview
11.6.5 AGC Biologics Latest Developments
11.7 Samsung Biologics
11.7.1 Samsung Biologics Company Information
11.7.2 Samsung Biologics Biosimilar Contract Manufacturing Product Offered
11.7.3 Samsung Biologics Biosimilar Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Samsung Biologics Main Business Overview
11.7.5 Samsung Biologics Latest Developments
11.8 WuXi Biologics
11.8.1 WuXi Biologics Company Information
11.8.2 WuXi Biologics Biosimilar Contract Manufacturing Product Offered
11.8.3 WuXi Biologics Biosimilar Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 WuXi Biologics Main Business Overview
11.8.5 WuXi Biologics Latest Developments
11.9 Element Materials Technology
11.9.1 Element Materials Technology Company Information
11.9.2 Element Materials Technology Biosimilar Contract Manufacturing Product Offered
11.9.3 Element Materials Technology Biosimilar Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Element Materials Technology Main Business Overview
11.9.5 Element Materials Technology Latest Developments
11.10 Rentschler Biopharma SE
11.10.1 Rentschler Biopharma SE Company Information
11.10.2 Rentschler Biopharma SE Biosimilar Contract Manufacturing Product Offered
11.10.3 Rentschler Biopharma SE Biosimilar Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Rentschler Biopharma SE Main Business Overview
11.10.5 Rentschler Biopharma SE Latest Developments
11.11 Avid Bioservices, Inc.
11.11.1 Avid Bioservices, Inc. Company Information
11.11.2 Avid Bioservices, Inc. Biosimilar Contract Manufacturing Product Offered
11.11.3 Avid Bioservices, Inc. Biosimilar Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Avid Bioservices, Inc. Main Business Overview
11.11.5 Avid Bioservices, Inc. Latest Developments
11.12 Alcami Corporation, Inc.
11.12.1 Alcami Corporation, Inc. Company Information
11.12.2 Alcami Corporation, Inc. Biosimilar Contract Manufacturing Product Offered
11.12.3 Alcami Corporation, Inc. Biosimilar Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Alcami Corporation, Inc. Main Business Overview
11.12.5 Alcami Corporation, Inc. Latest Developments
11.13 Fujifilm Kyowa Kirin Biologics Co., Ltd.
11.13.1 Fujifilm Kyowa Kirin Biologics Co., Ltd. Company Information
11.13.2 Fujifilm Kyowa Kirin Biologics Co., Ltd. Biosimilar Contract Manufacturing Product Offered
11.13.3 Fujifilm Kyowa Kirin Biologics Co., Ltd. Biosimilar Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Fujifilm Kyowa Kirin Biologics Co., Ltd. Main Business Overview
11.13.5 Fujifilm Kyowa Kirin Biologics Co., Ltd. Latest Developments
11.14 Thermo Fisher Scientific Inc.
11.14.1 Thermo Fisher Scientific Inc. Company Information
11.14.2 Thermo Fisher Scientific Inc. Biosimilar Contract Manufacturing Product Offered
11.14.3 Thermo Fisher Scientific Inc. Biosimilar Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Thermo Fisher Scientific Inc. Main Business Overview
11.14.5 Thermo Fisher Scientific Inc. Latest Developments
11.15 Almac Group
11.15.1 Almac Group Company Information
11.15.2 Almac Group Biosimilar Contract Manufacturing Product Offered
11.15.3 Almac Group Biosimilar Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 Almac Group Main Business Overview
11.15.5 Almac Group Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂